Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Zacks News
3 Reasons Why Growth Investors Shouldn't Overlook Cross Country (CCRN)
by Zacks Equity Research
Cross Country (CCRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why You Should Retain WEX Stock in Your Portfolio
by Zacks Equity Research
Product and service quality and a deep understanding of customers' operational needs provide revenue stability to WEX.
6 Reasons Why You Should Bet on Rollins (ROL) Stock Now
by Zacks Equity Research
Acquisitions are a significant catalyst for Rollins' (ROL) business development and are helping the company to expand its global brand recognition and geographical footprint.
Reasons to Retain FactSet (FDS) Stock in Your Portfolio Now
by Zacks Equity Research
FactSet (FDS) is currently benefiting from a growing customer base and a strong global presence.
Here's Why Investors Should Retain Fiserv (FISV) Stock Now
by Zacks Equity Research
The recent acquisition of Finxact expands Fiserv's (FISV) account processing, digital and payments solutions.
Here's Why Investors Should Retain Aptiv (APTV) Stock Now
by Zacks Equity Research
A strong cash position and calculated buyouts boost Aptiv (APTV).
Is Barrett Business Services (BBSI) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Barrett Business Services (BBSI) and Cross Country Healthcare (CCRN) have performed compared to their sector so far this year.
Zacks.com featured highlights include Country Healthcare, CVR Energy, Delek US Holdings, Boise Cascade and Builders FirstSource
by Zacks Equity Research
Country Healthcare, CVR Energy, Delek US Holdings, Boise Cascade and Builders FirstSource are part of the Zacks Screen of the Week article.
Insperity (NSP) Seems an Attractive Pick Now: Here's Why
by Zacks Equity Research
Insperity (NSP) is currently gaining on progress in the professional employer organization or the PEO industry.
Why You Should Retain Omnicom (OMC) in Your Portfolio Now
by Zacks Equity Research
Omnicom (OMC) continues to focus on investing in high-growth areas related to technology and data.
6 Reasons Why You Should Bet on Trane Technologies (TT) Now
by Zacks Equity Research
Trane Technologies (TT) remains focused on improving the quality of its products and services and operating efficiencies to achieve sustained improvement in earnings and cash flow.
Here's Why You Should Retain Republic Services (RSG) Now
by Zacks Equity Research
Operational efficiency and investor-friendly measures boost Republic Services (RSG).
5 Broker-Favorite Stocks to Tide Over the Market Tempest
by Maharathi Basu
Broker-favorite stocks like Country Healthcare (CCRN), CVR Energy (CVI), Delek US Holdings (DK), Boise Cascade (BCC) and Builders FirstSource (BLDR) should be on an investor's watch list.
Here's Why You Should Retain Equifax (EFX) Stock for Now
by Zacks Equity Research
Technology transition and a solid clientele boost Equifax (EFX).
Here's Why You Should Retain Waste Connections (WCN) Now
by Zacks Equity Research
Low-overhead, robust operational model and shareholder-prone moves boost Waste Connections (WCN).
Reasons Why You Should Invest in H&R Block (HRB) Stock Now
by Zacks Equity Research
H&R Block (HRB) is focused on using human expertise and technological infrastructure to drive innovation.
Here's Why You Should Invest in Charles River (CRAI) Stock Now
by Zacks Equity Research
Proficiency in multiple industries helps Charles River (CRAI) meet varying client needs and offer other innovative services.
Here's Why You Should Retain Broadridge (BR) Stock for Now
by Zacks Equity Research
Broadridge's (BR) Global Technology and Operations business looks well poised to be driven by the Itiviti acquisition.
Here's Why You Should Retain Interpublic (IPG) Stock for Now
by Zacks Equity Research
A strong cash position and investor-friendly moves boost Interpublic (IPG).
Reasons to Add Paychex (PAYX) Stock to Your Portfolio Now
by Zacks Equity Research
Paychex's (PAYX) solid business model, diversified products and services, and strategic acquisitions boost top-line growth.
Why You Should Retain Envestnet (ENV) in Your Portfolio Now
by Zacks Equity Research
Recurring revenue-generation capacity and technological advancement aid Envestnet (ENV).
Here's Why You Should Hold ICF International (ICFI) Stock Now
by Zacks Equity Research
ICF International (ICF) is seeing a significant increase in revenues from its high-growth markets.
6 Reasons Why You Must Add Avis Budget (CAR) to Your Portfolio
by Zacks Equity Research
Enhanced technology and shareholder-friendly measures boost Avis Budget (CAR) stock.
Why Clean Harbors (CLH) is an Attractive Bet for Investors
by Zacks Equity Research
Solid shareholder-friendly measures and capital investments boost Clean Harbors (CLH) stock.
Accenture (ACN) to Snap Up ALBERT to Boost Presence in Japan
by Zacks Equity Research
The acquisition is expected to strengthen Accenture's (ACN) data and AI capabilities.